Home > News
-
The USP15 Biological Thermostat: lead author Joan Seoane underlines findings published in Nature Medicine
-
The USP15 Biological Thermostat: a Promising Novel Therapeutic Target in Cancer
Barcelona, 19th February 2012.- After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d’Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise. USP15 promotes tumor progression by activating the TGFβ pathway. Playing a highly significant oncogenic role in glioblastoma, TGFß is a powerful immunosuppressant allowing the tumor to escape the host immune system. It also acts as an angiogenic factor inducing blood vessels, promotes tumoral invasion, activates cancer stem cells, and in some tumors, induces metastases.
-
In The Lancet: Combining 2 anti-HER2 drugs may provide better preoperative breast cancer treatment
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent.
-
VHIO´s Javier Cortes comments: Two Anti-HER2 Antibodies Better than One
A recent paper published in The New England Journal of Medicine, shows that Pertuzumab, an anti-HER 2 antibody, recognizes a different epitope of HER2 than Trastuzumab and behaves differently. In patients with metastatic breast cancer, the combination of the two antibodies plus docetaxel significantly increased progression-free survival. Co-author Javier Cortés, Principle Investigator of VHIO´s Breast Cancer and Melanoma Group, describes the CLEOPATRA (CLinical Evaluation Of Pertuzumab And TRAstuzumab) randomized trial, the importance and implications of the findings, as well as signposts future directions.
-
Science comes to VHIO: 23 January 2012
Marking the second in the prestigious series of talks: VHIO Meet the Editors, Science´s Paula Kiberstis, Senior Editor, cancer research, will be joining us to deliver what promises to be a highly insightful presentation on Demystifying Science.
